Does anyone have a good idea of the price per unit or estimated volumes of all these product wins. I am just trying to get some sense of projected volumes and revenues as products ramp.
Companys like Stifel and MS have been buying stock as of march 31.... see the nasdaq institutional print for institutions. How nice to be able to downgrade the stock and then start buying it.
Just thinking - is this some kind of brand new item thats never been tested or verified. I would assume there are many commonly used "excipents" that are well known and proven in the drug world. Couldn't this have been known like 18 months ago?
Maybe that's not the case with a new drug or mixture - but it seems odd that i have never once heard of this from any other drug company ever ?? (and i am long time holder of rmti)
saw that too, but very amazed that that alone would destroy the stock and that these prices have zero interest now. even insiders that bought open market at 4$ in Aug. have no interest at .80 cents.